CTLA4 and neoplasm: For example, anti-CTLA-4 antibodies are reported to enhance macrophage-induced ADCC of Tregs, promoting cancer clearance, whereas MAPKi can promote the secretion of TAM-derived angiogenic factors, supporting tumor growth.